MMP9 and Stroke: Similar to the above-mentioned results in MMP-9−/− mice, administration of the MMP inhibitor GM6001 at the onset of post-stroke reperfusion had no effect on leakage of the 3 kDa-dextran through the BBB at 30 min, 3 or 24 h after tFCI (Fig. 1d,e).